nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP3A4—type 2 diabetes mellitus	0.152	1	CbGaD
Montelukast—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.0706	0.119	CbGbCtD
Montelukast—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.0406	0.0685	CbGbCtD
Montelukast—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0325	0.0548	CbGbCtD
Montelukast—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0301	0.0507	CbGbCtD
Montelukast—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0301	0.0507	CbGbCtD
Montelukast—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0277	0.0468	CbGbCtD
Montelukast—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.024	0.0405	CbGbCtD
Montelukast—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0228	0.0384	CbGbCtD
Montelukast—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0218	0.0368	CbGbCtD
Montelukast—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0192	0.0324	CbGbCtD
Montelukast—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0173	0.0293	CbGbCtD
Montelukast—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0167	0.0282	CbGbCtD
Montelukast—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.016	0.027	CbGbCtD
Montelukast—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0155	0.0261	CbGbCtD
Montelukast—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0153	0.0258	CbGbCtD
Montelukast—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0142	0.024	CbGbCtD
Montelukast—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0126	0.0213	CbGbCtD
Montelukast—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0121	0.0204	CbGbCtD
Montelukast—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0121	0.0204	CbGbCtD
Montelukast—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0112	0.0188	CbGbCtD
Montelukast—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0109	0.0184	CbGbCtD
Montelukast—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0108	0.0182	CbGbCtD
Montelukast—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00986	0.0166	CbGbCtD
Montelukast—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00973	0.0164	CbGbCtD
Montelukast—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00917	0.0155	CbGbCtD
Montelukast—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0089	0.015	CbGbCtD
Montelukast—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00879	0.0148	CbGbCtD
Montelukast—CYP2C8—Losartan—type 2 diabetes mellitus	0.00812	0.0137	CbGbCtD
Montelukast—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00778	0.0131	CbGbCtD
Montelukast—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00704	0.0119	CbGbCtD
Montelukast—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00619	0.0105	CbGbCtD
Montelukast—CYP2C9—Losartan—type 2 diabetes mellitus	0.00567	0.00956	CbGbCtD
Montelukast—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00533	0.009	CbGbCtD
Montelukast—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00511	0.00862	CbGbCtD
Montelukast—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00511	0.00862	CbGbCtD
Montelukast—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00483	0.00816	CbGbCtD
Montelukast—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0036	0.00608	CbGbCtD
Montelukast—CYP3A4—Losartan—type 2 diabetes mellitus	0.00329	0.00556	CbGbCtD
Montelukast—CYSLTR1—pancreas—type 2 diabetes mellitus	0.000415	0.0975	CbGeAlD
Montelukast—CYSLTR1—adipose tissue—type 2 diabetes mellitus	0.000377	0.0884	CbGeAlD
Montelukast—ALOX5—islet of Langerhans—type 2 diabetes mellitus	0.000358	0.084	CbGeAlD
Montelukast—PTGS1—artery—type 2 diabetes mellitus	0.000299	0.0701	CbGeAlD
Montelukast—ALOX5—cardiovascular system—type 2 diabetes mellitus	0.000259	0.0607	CbGeAlD
Montelukast—PTGS1—endothelium—type 2 diabetes mellitus	0.000252	0.0593	CbGeAlD
Montelukast—ALOX5—pancreas—type 2 diabetes mellitus	0.000251	0.059	CbGeAlD
Montelukast—ALOX5—adipose tissue—type 2 diabetes mellitus	0.000228	0.0536	CbGeAlD
Montelukast—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000201	0.0472	CbGeAlD
Montelukast—SLCO2B1—kidney—type 2 diabetes mellitus	0.000195	0.0457	CbGeAlD
Montelukast—SLCO2B1—adipose tissue—type 2 diabetes mellitus	0.000176	0.0412	CbGeAlD
Montelukast—ALOX5—liver—type 2 diabetes mellitus	0.00016	0.0376	CbGeAlD
Montelukast—CYP2A6—liver—type 2 diabetes mellitus	0.000141	0.0331	CbGeAlD
Montelukast—CYP2C8—kidney—type 2 diabetes mellitus	0.000125	0.0294	CbGeAlD
Montelukast—SLCO2B1—liver—type 2 diabetes mellitus	0.000123	0.0289	CbGeAlD
Montelukast—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000114	0.0267	CbGeAlD
Montelukast—Oedema—Valsartan—type 2 diabetes mellitus	0.00011	0.000641	CcSEcCtD
Montelukast—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00011	0.00064	CcSEcCtD
Montelukast—Infection—Valsartan—type 2 diabetes mellitus	0.00011	0.000637	CcSEcCtD
Montelukast—Rash—Glipizide—type 2 diabetes mellitus	0.00011	0.000637	CcSEcCtD
Montelukast—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00011	0.000636	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00011	0.000636	CcSEcCtD
Montelukast—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000109	0.000636	CcSEcCtD
Montelukast—Oedema—Orlistat—type 2 diabetes mellitus	0.000109	0.000634	CcSEcCtD
Montelukast—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000109	0.000634	CcSEcCtD
Montelukast—Headache—Glipizide—type 2 diabetes mellitus	0.000109	0.000633	CcSEcCtD
Montelukast—Tremor—Irbesartan—type 2 diabetes mellitus	0.000109	0.000633	CcSEcCtD
Montelukast—Palpitations—Metformin—type 2 diabetes mellitus	0.000109	0.000632	CcSEcCtD
Montelukast—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000109	0.000631	CcSEcCtD
Montelukast—Infection—Orlistat—type 2 diabetes mellitus	0.000108	0.00063	CcSEcCtD
Montelukast—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000108	0.000629	CcSEcCtD
Montelukast—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000108	0.000628	CcSEcCtD
Montelukast—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000627	CcSEcCtD
Montelukast—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000108	0.000626	CcSEcCtD
Montelukast—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000107	0.000623	CcSEcCtD
Montelukast—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000107	0.000623	CcSEcCtD
Montelukast—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000107	0.000621	CcSEcCtD
Montelukast—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000621	CcSEcCtD
Montelukast—Agitation—Irbesartan—type 2 diabetes mellitus	0.000107	0.000621	CcSEcCtD
Montelukast—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000107	0.000621	CcSEcCtD
Montelukast—Urticaria—Glyburide—type 2 diabetes mellitus	0.000106	0.000618	CcSEcCtD
Montelukast—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000106	0.000617	CcSEcCtD
Montelukast—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000106	0.000616	CcSEcCtD
Montelukast—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000106	0.000615	CcSEcCtD
Montelukast—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000106	0.000615	CcSEcCtD
Montelukast—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000106	0.000614	CcSEcCtD
Montelukast—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000105	0.000611	CcSEcCtD
Montelukast—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000105	0.00061	CcSEcCtD
Montelukast—Myalgia—Metformin—type 2 diabetes mellitus	0.000105	0.000609	CcSEcCtD
Montelukast—Headache—Pioglitazone—type 2 diabetes mellitus	0.000104	0.000606	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000104	0.000605	CcSEcCtD
Montelukast—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000104	0.0244	CbGeAlD
Montelukast—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000104	0.000603	CcSEcCtD
Montelukast—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000104	0.000602	CcSEcCtD
Montelukast—Nausea—Glipizide—type 2 diabetes mellitus	0.000103	0.0006	CcSEcCtD
Montelukast—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000103	0.000599	CcSEcCtD
Montelukast—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000103	0.000597	CcSEcCtD
Montelukast—Pain—Gliclazide—type 2 diabetes mellitus	0.000103	0.000597	CcSEcCtD
Montelukast—Tremor—Losartan—type 2 diabetes mellitus	0.000103	0.000595	CcSEcCtD
Montelukast—Rash—Glimepiride—type 2 diabetes mellitus	0.000102	0.000594	CcSEcCtD
Montelukast—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000102	0.000594	CcSEcCtD
Montelukast—Rash—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000592	CcSEcCtD
Montelukast—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000592	CcSEcCtD
Montelukast—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000102	0.000592	CcSEcCtD
Montelukast—Headache—Glimepiride—type 2 diabetes mellitus	0.000102	0.000591	CcSEcCtD
Montelukast—PTGS1—kidney—type 2 diabetes mellitus	0.000102	0.0239	CbGeAlD
Montelukast—Cough—Irbesartan—type 2 diabetes mellitus	0.000101	0.000589	CcSEcCtD
Montelukast—Headache—Sitagliptin—type 2 diabetes mellitus	0.000101	0.000589	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000101	0.000584	CcSEcCtD
Montelukast—Agitation—Losartan—type 2 diabetes mellitus	0.000101	0.000584	CcSEcCtD
Montelukast—Oedema—Metformin—type 2 diabetes mellitus	0.000101	0.000584	CcSEcCtD
Montelukast—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.0001	0.000582	CcSEcCtD
Montelukast—Angioedema—Losartan—type 2 diabetes mellitus	0.0001	0.000581	CcSEcCtD
Montelukast—Infection—Metformin—type 2 diabetes mellitus	9.99e-05	0.00058	CcSEcCtD
Montelukast—Insomnia—Valsartan—type 2 diabetes mellitus	9.99e-05	0.00058	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.94e-05	0.000577	CcSEcCtD
Montelukast—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.92e-05	0.000576	CcSEcCtD
Montelukast—Myalgia—Irbesartan—type 2 diabetes mellitus	9.9e-05	0.000575	CcSEcCtD
Montelukast—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.9e-05	0.000575	CcSEcCtD
Montelukast—Insomnia—Orlistat—type 2 diabetes mellitus	9.87e-05	0.000573	CcSEcCtD
Montelukast—Anxiety—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000573	CcSEcCtD
Montelukast—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.86e-05	0.000573	CcSEcCtD
Montelukast—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.86e-05	0.000573	CcSEcCtD
Montelukast—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.85e-05	0.000572	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000571	CcSEcCtD
Montelukast—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.83e-05	0.000571	CcSEcCtD
Montelukast—Somnolence—Valsartan—type 2 diabetes mellitus	9.82e-05	0.00057	CcSEcCtD
Montelukast—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.8e-05	0.000569	CcSEcCtD
Montelukast—Skin disorder—Metformin—type 2 diabetes mellitus	9.77e-05	0.000567	CcSEcCtD
Montelukast—Immune system disorder—Ramipril—type 2 diabetes mellitus	9.74e-05	0.000565	CcSEcCtD
Montelukast—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.72e-05	0.000565	CcSEcCtD
Montelukast—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000564	CcSEcCtD
Montelukast—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.68e-05	0.000562	CcSEcCtD
Montelukast—Palpitations—Losartan—type 2 diabetes mellitus	9.67e-05	0.000562	CcSEcCtD
Montelukast—Nausea—Glimepiride—type 2 diabetes mellitus	9.64e-05	0.00056	CcSEcCtD
Montelukast—Nausea—Sitagliptin—type 2 diabetes mellitus	9.61e-05	0.000558	CcSEcCtD
Montelukast—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.61e-05	0.000558	CcSEcCtD
Montelukast—Asthenia—Glyburide—type 2 diabetes mellitus	9.61e-05	0.000558	CcSEcCtD
Montelukast—Cough—Losartan—type 2 diabetes mellitus	9.55e-05	0.000555	CcSEcCtD
Montelukast—Urticaria—Gliclazide—type 2 diabetes mellitus	9.55e-05	0.000555	CcSEcCtD
Montelukast—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.54e-05	0.000554	CcSEcCtD
Montelukast—Fatigue—Valsartan—type 2 diabetes mellitus	9.52e-05	0.000553	CcSEcCtD
Montelukast—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.5e-05	0.000552	CcSEcCtD
Montelukast—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.5e-05	0.000552	CcSEcCtD
Montelukast—Oedema—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000551	CcSEcCtD
Montelukast—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000551	CcSEcCtD
Montelukast—Pruritus—Glyburide—type 2 diabetes mellitus	9.47e-05	0.00055	CcSEcCtD
Montelukast—Mental disorder—Ramipril—type 2 diabetes mellitus	9.44e-05	0.000548	CcSEcCtD
Montelukast—Infection—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000548	CcSEcCtD
Montelukast—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.42e-05	0.000547	CcSEcCtD
Montelukast—Fatigue—Orlistat—type 2 diabetes mellitus	9.41e-05	0.000546	CcSEcCtD
Montelukast—Pain—Orlistat—type 2 diabetes mellitus	9.33e-05	0.000542	CcSEcCtD
Montelukast—Myalgia—Losartan—type 2 diabetes mellitus	9.32e-05	0.000541	CcSEcCtD
Montelukast—Arthralgia—Losartan—type 2 diabetes mellitus	9.32e-05	0.000541	CcSEcCtD
Montelukast—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.31e-05	0.000541	CcSEcCtD
Montelukast—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.31e-05	0.000541	CcSEcCtD
Montelukast—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.29e-05	0.00054	CcSEcCtD
Montelukast—Anxiety—Losartan—type 2 diabetes mellitus	9.29e-05	0.000539	CcSEcCtD
Montelukast—Rash—Bromocriptine—type 2 diabetes mellitus	9.23e-05	0.000536	CcSEcCtD
Montelukast—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.23e-05	0.000536	CcSEcCtD
Montelukast—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000535	CcSEcCtD
Montelukast—Headache—Bromocriptine—type 2 diabetes mellitus	9.17e-05	0.000533	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.16e-05	0.000532	CcSEcCtD
Montelukast—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.16e-05	0.000532	CcSEcCtD
Montelukast—PTGS1—adipose tissue—type 2 diabetes mellitus	9.16e-05	0.0215	CbGeAlD
Montelukast—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.03e-05	0.000524	CcSEcCtD
Montelukast—Paraesthesia—Metformin—type 2 diabetes mellitus	9.03e-05	0.000524	CcSEcCtD
Montelukast—Muscle spasms—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000524	CcSEcCtD
Montelukast—Somnolence—Metformin—type 2 diabetes mellitus	8.94e-05	0.000519	CcSEcCtD
Montelukast—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.93e-05	0.000519	CcSEcCtD
Montelukast—Oedema—Losartan—type 2 diabetes mellitus	8.93e-05	0.000519	CcSEcCtD
Montelukast—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.92e-05	0.000518	CcSEcCtD
Montelukast—Infection—Losartan—type 2 diabetes mellitus	8.87e-05	0.000515	CcSEcCtD
Montelukast—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.86e-05	0.000514	CcSEcCtD
Montelukast—Dyspepsia—Metformin—type 2 diabetes mellitus	8.85e-05	0.000514	CcSEcCtD
Montelukast—Tremor—Ramipril—type 2 diabetes mellitus	8.79e-05	0.000511	CcSEcCtD
Montelukast—Urticaria—Valsartan—type 2 diabetes mellitus	8.77e-05	0.00051	CcSEcCtD
Montelukast—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.76e-05	0.000509	CcSEcCtD
Montelukast—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.75e-05	0.000508	CcSEcCtD
Montelukast—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.73e-05	0.000507	CcSEcCtD
Montelukast—Nausea—Bromocriptine—type 2 diabetes mellitus	8.7e-05	0.000505	CcSEcCtD
Montelukast—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.68e-05	0.000504	CcSEcCtD
Montelukast—Fatigue—Metformin—type 2 diabetes mellitus	8.67e-05	0.000504	CcSEcCtD
Montelukast—Urticaria—Orlistat—type 2 diabetes mellitus	8.67e-05	0.000503	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.65e-05	0.000502	CcSEcCtD
Montelukast—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.63e-05	0.000501	CcSEcCtD
Montelukast—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.63e-05	0.000501	CcSEcCtD
Montelukast—Asthenia—Gliclazide—type 2 diabetes mellitus	8.63e-05	0.000501	CcSEcCtD
Montelukast—Agitation—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000501	CcSEcCtD
Montelukast—Angioedema—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000498	CcSEcCtD
Montelukast—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000495	CcSEcCtD
Montelukast—Vomiting—Glyburide—type 2 diabetes mellitus	8.51e-05	0.000494	CcSEcCtD
Montelukast—Pruritus—Gliclazide—type 2 diabetes mellitus	8.51e-05	0.000494	CcSEcCtD
Montelukast—CYP3A4—kidney—type 2 diabetes mellitus	8.49e-05	0.0199	CbGeAlD
Montelukast—Rash—Glyburide—type 2 diabetes mellitus	8.44e-05	0.00049	CcSEcCtD
Montelukast—Somnolence—Irbesartan—type 2 diabetes mellitus	8.44e-05	0.00049	CcSEcCtD
Montelukast—Dermatitis—Glyburide—type 2 diabetes mellitus	8.43e-05	0.00049	CcSEcCtD
Montelukast—Headache—Glyburide—type 2 diabetes mellitus	8.39e-05	0.000487	CcSEcCtD
Montelukast—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000485	CcSEcCtD
Montelukast—Palpitations—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000482	CcSEcCtD
Montelukast—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.23e-05	0.000478	CcSEcCtD
Montelukast—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.22e-05	0.000478	CcSEcCtD
Montelukast—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.19e-05	0.000476	CcSEcCtD
Montelukast—Cough—Ramipril—type 2 diabetes mellitus	8.19e-05	0.000476	CcSEcCtD
Montelukast—Fatigue—Irbesartan—type 2 diabetes mellitus	8.18e-05	0.000475	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.14e-05	0.000473	CcSEcCtD
Montelukast—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.14e-05	0.000473	CcSEcCtD
Montelukast—Convulsion—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000472	CcSEcCtD
Montelukast—Pain—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000471	CcSEcCtD
Montelukast—Insomnia—Losartan—type 2 diabetes mellitus	8.08e-05	0.000469	CcSEcCtD
Montelukast—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.04e-05	0.000467	CcSEcCtD
Montelukast—Paraesthesia—Losartan—type 2 diabetes mellitus	8.02e-05	0.000466	CcSEcCtD
Montelukast—Urticaria—Metformin—type 2 diabetes mellitus	7.99e-05	0.000464	CcSEcCtD
Montelukast—Arthralgia—Ramipril—type 2 diabetes mellitus	7.99e-05	0.000464	CcSEcCtD
Montelukast—Myalgia—Ramipril—type 2 diabetes mellitus	7.99e-05	0.000464	CcSEcCtD
Montelukast—Anxiety—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000462	CcSEcCtD
Montelukast—Nausea—Glyburide—type 2 diabetes mellitus	7.95e-05	0.000462	CcSEcCtD
Montelukast—Abdominal pain—Metformin—type 2 diabetes mellitus	7.95e-05	0.000462	CcSEcCtD
Montelukast—Dizziness—Gliclazide—type 2 diabetes mellitus	7.95e-05	0.000462	CcSEcCtD
Montelukast—Somnolence—Losartan—type 2 diabetes mellitus	7.94e-05	0.000461	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000461	CcSEcCtD
Montelukast—Asthenia—Valsartan—type 2 diabetes mellitus	7.92e-05	0.00046	CcSEcCtD
Montelukast—CYP2C8—liver—type 2 diabetes mellitus	7.92e-05	0.0186	CbGeAlD
Montelukast—Dyspepsia—Losartan—type 2 diabetes mellitus	7.86e-05	0.000457	CcSEcCtD
Montelukast—Asthenia—Orlistat—type 2 diabetes mellitus	7.83e-05	0.000455	CcSEcCtD
Montelukast—Pruritus—Valsartan—type 2 diabetes mellitus	7.81e-05	0.000454	CcSEcCtD
Montelukast—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000451	CcSEcCtD
Montelukast—Pruritus—Orlistat—type 2 diabetes mellitus	7.72e-05	0.000448	CcSEcCtD
Montelukast—Fatigue—Losartan—type 2 diabetes mellitus	7.7e-05	0.000447	CcSEcCtD
Montelukast—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000445	CcSEcCtD
Montelukast—Oedema—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000445	CcSEcCtD
Montelukast—Vomiting—Gliclazide—type 2 diabetes mellitus	7.64e-05	0.000444	CcSEcCtD
Montelukast—Pain—Losartan—type 2 diabetes mellitus	7.64e-05	0.000444	CcSEcCtD
Montelukast—Rash—Gliclazide—type 2 diabetes mellitus	7.58e-05	0.00044	CcSEcCtD
Montelukast—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.57e-05	0.00044	CcSEcCtD
Montelukast—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.56e-05	0.000439	CcSEcCtD
Montelukast—Urticaria—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000438	CcSEcCtD
Montelukast—Headache—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.000437	CcSEcCtD
Montelukast—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.51e-05	0.000436	CcSEcCtD
Montelukast—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000436	CcSEcCtD
Montelukast—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000436	CcSEcCtD
Montelukast—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000435	CcSEcCtD
Montelukast—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.47e-05	0.000434	CcSEcCtD
Montelukast—Skin disorder—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000432	CcSEcCtD
Montelukast—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.3e-05	0.000424	CcSEcCtD
Montelukast—Dizziness—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000424	CcSEcCtD
Montelukast—Dizziness—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000419	CcSEcCtD
Montelukast—Asthenia—Metformin—type 2 diabetes mellitus	7.22e-05	0.000419	CcSEcCtD
Montelukast—Nausea—Gliclazide—type 2 diabetes mellitus	7.14e-05	0.000415	CcSEcCtD
Montelukast—Pruritus—Metformin—type 2 diabetes mellitus	7.12e-05	0.000413	CcSEcCtD
Montelukast—Urticaria—Losartan—type 2 diabetes mellitus	7.1e-05	0.000412	CcSEcCtD
Montelukast—Abdominal pain—Losartan—type 2 diabetes mellitus	7.06e-05	0.00041	CcSEcCtD
Montelukast—Body temperature increased—Losartan—type 2 diabetes mellitus	7.06e-05	0.00041	CcSEcCtD
Montelukast—CYP2C9—liver—type 2 diabetes mellitus	7.04e-05	0.0165	CbGeAlD
Montelukast—Vomiting—Valsartan—type 2 diabetes mellitus	7.02e-05	0.000408	CcSEcCtD
Montelukast—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.99e-05	0.000406	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000405	CcSEcCtD
Montelukast—Rash—Valsartan—type 2 diabetes mellitus	6.96e-05	0.000404	CcSEcCtD
Montelukast—Dermatitis—Valsartan—type 2 diabetes mellitus	6.96e-05	0.000404	CcSEcCtD
Montelukast—Vomiting—Orlistat—type 2 diabetes mellitus	6.94e-05	0.000403	CcSEcCtD
Montelukast—Insomnia—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000402	CcSEcCtD
Montelukast—Headache—Valsartan—type 2 diabetes mellitus	6.92e-05	0.000402	CcSEcCtD
Montelukast—Diarrhoea—Metformin—type 2 diabetes mellitus	6.88e-05	0.0004	CcSEcCtD
Montelukast—Rash—Orlistat—type 2 diabetes mellitus	6.88e-05	0.0004	CcSEcCtD
Montelukast—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000399	CcSEcCtD
Montelukast—Dermatitis—Orlistat—type 2 diabetes mellitus	6.87e-05	0.000399	CcSEcCtD
Montelukast—Headache—Orlistat—type 2 diabetes mellitus	6.84e-05	0.000397	CcSEcCtD
Montelukast—Asthenia—Irbesartan—type 2 diabetes mellitus	6.81e-05	0.000395	CcSEcCtD
Montelukast—Somnolence—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000395	CcSEcCtD
Montelukast—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000392	CcSEcCtD
Montelukast—Pruritus—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.00039	CcSEcCtD
Montelukast—Dizziness—Metformin—type 2 diabetes mellitus	6.65e-05	0.000386	CcSEcCtD
Montelukast—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000384	CcSEcCtD
Montelukast—Fatigue—Ramipril—type 2 diabetes mellitus	6.6e-05	0.000383	CcSEcCtD
Montelukast—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.58e-05	0.000382	CcSEcCtD
Montelukast—Nausea—Valsartan—type 2 diabetes mellitus	6.56e-05	0.000381	CcSEcCtD
Montelukast—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.000377	CcSEcCtD
Montelukast—Nausea—Orlistat—type 2 diabetes mellitus	6.48e-05	0.000376	CcSEcCtD
Montelukast—Asthenia—Losartan—type 2 diabetes mellitus	6.41e-05	0.000372	CcSEcCtD
Montelukast—Vomiting—Metformin—type 2 diabetes mellitus	6.39e-05	0.000371	CcSEcCtD
Montelukast—Rash—Metformin—type 2 diabetes mellitus	6.34e-05	0.000368	CcSEcCtD
Montelukast—Dermatitis—Metformin—type 2 diabetes mellitus	6.34e-05	0.000368	CcSEcCtD
Montelukast—Pruritus—Losartan—type 2 diabetes mellitus	6.32e-05	0.000367	CcSEcCtD
Montelukast—Headache—Metformin—type 2 diabetes mellitus	6.3e-05	0.000366	CcSEcCtD
Montelukast—Dizziness—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000364	CcSEcCtD
Montelukast—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000364	CcSEcCtD
Montelukast—Diarrhoea—Losartan—type 2 diabetes mellitus	6.11e-05	0.000355	CcSEcCtD
Montelukast—Urticaria—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000353	CcSEcCtD
Montelukast—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000352	CcSEcCtD
Montelukast—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000352	CcSEcCtD
Montelukast—Vomiting—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.00035	CcSEcCtD
Montelukast—Rash—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000348	CcSEcCtD
Montelukast—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000347	CcSEcCtD
Montelukast—Nausea—Metformin—type 2 diabetes mellitus	5.97e-05	0.000347	CcSEcCtD
Montelukast—Headache—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000345	CcSEcCtD
Montelukast—Dizziness—Losartan—type 2 diabetes mellitus	5.91e-05	0.000343	CcSEcCtD
Montelukast—Vomiting—Losartan—type 2 diabetes mellitus	5.68e-05	0.00033	CcSEcCtD
Montelukast—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.64e-05	0.000328	CcSEcCtD
Montelukast—Nausea—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000327	CcSEcCtD
Montelukast—Rash—Losartan—type 2 diabetes mellitus	5.63e-05	0.000327	CcSEcCtD
Montelukast—Dermatitis—Losartan—type 2 diabetes mellitus	5.63e-05	0.000327	CcSEcCtD
Montelukast—Headache—Losartan—type 2 diabetes mellitus	5.6e-05	0.000325	CcSEcCtD
Montelukast—Asthenia—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000319	CcSEcCtD
Montelukast—Pruritus—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000315	CcSEcCtD
Montelukast—CYP3A4—liver—type 2 diabetes mellitus	5.36e-05	0.0126	CbGeAlD
Montelukast—Nausea—Losartan—type 2 diabetes mellitus	5.31e-05	0.000308	CcSEcCtD
Montelukast—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000304	CcSEcCtD
Montelukast—Dizziness—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000294	CcSEcCtD
Montelukast—Vomiting—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000283	CcSEcCtD
Montelukast—Rash—Ramipril—type 2 diabetes mellitus	4.83e-05	0.00028	CcSEcCtD
Montelukast—Dermatitis—Ramipril—type 2 diabetes mellitus	4.82e-05	0.00028	CcSEcCtD
Montelukast—Headache—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000279	CcSEcCtD
Montelukast—Nausea—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000264	CcSEcCtD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.48e-06	0.000108	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC2A4—type 2 diabetes mellitus	8.4e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GCG—type 2 diabetes mellitus	8.4e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.38e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	8.36e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	8.28e-06	0.000106	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.23e-06	0.000105	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.06e-06	0.000103	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.03e-06	0.000102	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	8.01e-06	0.000102	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	8.01e-06	0.000102	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.85e-06	0.0001	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	7.83e-06	9.98e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.82e-06	9.97e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.74e-06	9.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.74e-06	9.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.74e-06	9.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.74e-06	9.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.74e-06	9.86e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	7.73e-06	9.85e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	7.66e-06	9.76e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.66e-06	9.76e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	7.62e-06	9.71e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	7.57e-06	9.65e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	7.57e-06	9.65e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	7.56e-06	9.63e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	7.56e-06	9.63e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	7.56e-06	9.63e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	7.56e-06	9.63e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	7.52e-06	9.59e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.49e-06	9.55e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	7.43e-06	9.46e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.38e-06	9.41e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	7.38e-06	9.4e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	7.38e-06	9.4e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	7.38e-06	9.4e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	7.33e-06	9.35e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	7.3e-06	9.31e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.27e-06	9.26e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	7.25e-06	9.24e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	7.24e-06	9.23e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.24e-06	9.23e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	7.21e-06	9.19e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.2e-06	9.18e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	7.2e-06	9.18e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	7.12e-06	9.07e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	7.11e-06	9.06e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	7.1e-06	9.05e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.08e-06	9.02e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.08e-06	9.02e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.06e-06	9e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.04e-06	8.97e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	6.97e-06	8.88e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	6.9e-06	8.8e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.9e-06	8.79e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.9e-06	8.79e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	6.83e-06	8.7e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.82e-06	8.69e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	6.8e-06	8.67e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.74e-06	8.59e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	6.72e-06	8.56e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.64e-06	8.46e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	6.62e-06	8.44e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	6.62e-06	8.44e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	6.62e-06	8.44e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	6.62e-06	8.44e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	6.59e-06	8.4e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.58e-06	8.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.58e-06	8.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.58e-06	8.38e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.54e-06	8.34e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	6.5e-06	8.28e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	6.45e-06	8.23e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	6.44e-06	8.21e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	6.43e-06	8.2e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.35e-06	8.09e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.31e-06	8.04e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.31e-06	8.04e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	6.3e-06	8.03e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	6.29e-06	8.02e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	6.28e-06	8e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	6.26e-06	7.98e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.19e-06	7.88e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.16e-06	7.85e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.16e-06	7.85e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	6.16e-06	7.85e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.07e-06	7.74e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.07e-06	7.74e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	6.05e-06	7.71e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.04e-06	7.7e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.01e-06	7.66e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.01e-06	7.65e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.01e-06	7.65e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.01e-06	7.65e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	5.99e-06	7.63e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	5.99e-06	7.63e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.97e-06	7.61e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.96e-06	7.6e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	5.96e-06	7.6e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	5.94e-06	7.56e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	5.86e-06	7.47e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.86e-06	7.47e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.86e-06	7.47e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.86e-06	7.47e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.86e-06	7.47e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	5.84e-06	7.45e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	5.84e-06	7.44e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	5.82e-06	7.42e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.81e-06	7.4e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.79e-06	7.38e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	5.78e-06	7.36e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	5.74e-06	7.31e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	5.74e-06	7.31e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	5.64e-06	7.19e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	5.55e-06	7.07e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	5.53e-06	7.04e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.51e-06	7.03e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	5.46e-06	6.96e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.43e-06	6.92e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.4e-06	6.89e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.39e-06	6.87e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.39e-06	6.87e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.39e-06	6.87e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.29e-06	6.74e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.24e-06	6.68e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.17e-06	6.59e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.16e-06	6.58e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.13e-06	6.54e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.09e-06	6.49e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.01e-06	6.38e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—INS—type 2 diabetes mellitus	4.99e-06	6.36e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.99e-06	6.35e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.99e-06	6.35e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.99e-06	6.35e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.99e-06	6.35e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.95e-06	6.3e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.95e-06	6.3e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.93e-06	6.28e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.92e-06	6.27e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.87e-06	6.21e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.87e-06	6.21e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.86e-06	6.19e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	4.81e-06	6.13e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.78e-06	6.09e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.75e-06	6.05e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.73e-06	6.02e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	4.72e-06	6.02e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.72e-06	6.01e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.67e-06	5.95e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.67e-06	5.95e-05	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—type 2 diabetes mellitus	4.64e-06	5.91e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.59e-06	5.85e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	4.58e-06	5.83e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.5e-06	5.74e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.44e-06	5.66e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.41e-06	5.62e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.39e-06	5.6e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.38e-06	5.58e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.38e-06	5.58e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	4.33e-06	5.52e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.28e-06	5.45e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.23e-06	5.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.15e-06	5.29e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.14e-06	5.28e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	4.14e-06	5.28e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.06e-06	5.18e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.06e-06	5.18e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.05e-06	5.17e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.03e-06	5.13e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.03e-06	5.13e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.01e-06	5.11e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4e-06	5.1e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.99e-06	5.08e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.98e-06	5.07e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.96e-06	5.05e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.96e-06	5.05e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.96e-06	5.05e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.95e-06	5.04e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.94e-06	5.02e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.87e-06	4.93e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.85e-06	4.91e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.84e-06	4.89e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.82e-06	4.87e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.79e-06	4.83e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	3.79e-06	4.83e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.77e-06	4.81e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.73e-06	4.76e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.73e-06	4.76e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.67e-06	4.67e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.59e-06	4.57e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.58e-06	4.56e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.55e-06	4.53e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.55e-06	4.53e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.55e-06	4.53e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.49e-06	4.44e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.48e-06	4.44e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.46e-06	4.4e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.44e-06	4.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.38e-06	4.31e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.3e-06	4.21e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.29e-06	4.19e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.25e-06	4.14e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.24e-06	4.13e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.22e-06	4.11e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.21e-06	4.09e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.21e-06	4.09e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.14e-06	4e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-06	3.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.08e-06	3.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.08e-06	3.93e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.07e-06	3.92e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.04e-06	3.87e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.96e-06	3.77e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.83e-06	3.6e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.83e-06	3.6e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.68e-06	3.41e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.66e-06	3.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.66e-06	3.38e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.64e-06	3.37e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.62e-06	3.34e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.61e-06	3.32e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.59e-06	3.3e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.53e-06	3.23e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.46e-06	3.14e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.42e-06	3.08e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.41e-06	3.07e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.37e-06	3.02e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.36e-06	3.01e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	2.93e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	2.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.3e-06	2.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.27e-06	2.89e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.18e-06	2.77e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.14e-06	2.72e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.11e-06	2.68e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.07e-06	2.64e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.03e-06	2.59e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.03e-06	2.58e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.01e-06	2.56e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2e-06	2.55e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.9e-06	2.43e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.76e-06	2.25e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.73e-06	2.21e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.59e-06	2.02e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.52e-06	1.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.52e-06	1.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.39e-06	1.77e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.3e-06	1.66e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	1.35e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.98e-07	8.89e-06	CbGpPWpGaD
